4th Quarter - Report

CAPITOL HILL CONSULTING GROUP for PURDUE PHARMA LLP

Period 4th Quarter 2008 Filed Jan 13, 2009 Signed by Tiffany Gerard, Office Manager

Official filing
Firm
CAPITOL HILL CONSULTING GROUP
Client
PURDUE PHARMA LLP
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Controlled Drug Substances Act (21 USC 13)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 380 (110th), S. 251 (110th), S. 242 (110th), H.R. 3610 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.